Helping you keep track of the latest market developments and challenges in this rapidly evolving and essential segment of the insurance industry.
Some of this year’s survey results are particularly encouraging. For example:
This year, we are also pleased to provide the key raw survey data, increasing transparency and widening the potential for extended use and analysis across the industry.
As part of our ‘Life & Health – Quick Read’ series, Dr. Achim Regenauer shares his insights and personal opinion on the timing of a […]
Costing hundreds of thousands, even millions of dollars per individual, several immuno- and gene therapies have been approved to-date. Usage expansion of such therapies is […]